Cidara receives BARDA award worth up to $339M for candidate that prevents flunews2025-10-03T11:06:08+00:00October 3rd, 2025|Endpoints News|
GSK’s ‘dream appointment’ in place to succeed Emma Walmsley; Astellas eliminates a top jobnews2025-10-03T11:00:09+00:00October 3rd, 2025|Endpoints News|
New protections could shield blockbusters from Medicare negotiations — expertsnews2025-10-02T19:30:08+00:00October 2nd, 2025|Endpoints News|
Vanda ends lawsuits against FDA as part of wide-ranging agreement with agencynews2025-10-02T18:37:35+00:00October 2nd, 2025|Endpoints News|
Ousted NIAID director says she objected to RFK Jr.’s ‘unscientific hostility’ to vaccinesnews2025-10-02T18:15:48+00:00October 2nd, 2025|Endpoints News|
Groups accuse drugmakers of conspiring to pressure UK over drug pricesnews2025-10-02T16:43:51+00:00October 2nd, 2025|Endpoints News|
What I heard during 36 hours of meetings out Westnews2025-10-02T16:19:52+00:00October 2nd, 2025|Endpoints News|
Hans Scientific invests $2B in US to avoid tariffs; Thermo Fisher inks up to $1B contractnews2025-10-02T15:28:42+00:00October 2nd, 2025|Endpoints News|
Despite shutdown, companies still plan to submit upcoming FDA applicationsnews2025-10-02T15:21:14+00:00October 2nd, 2025|Endpoints News|
Taysha may file for approval sooner than expected; Metagenomi ends work with Affini-Tnews2025-10-02T15:14:24+00:00October 2nd, 2025|Endpoints News|
